-
-
在线客服
-
-
-
-
我的收藏
-
我的订单
-
快速订购
-
-
-
| 产品编号 | CAS号 | 项目名称规格 | 分子式 | 加入购物车 |
|---|---|---|---|---|
| A998540 | Anti-CDH6 / K-Cadherin Reference Antibody (DS-6000a), Anti-CDH6 / K-Cadherin Reference Antibody (DS-6000a), |
|||
| A998541 | Anti-CDH6 / K-Cadherin Reference Antibody (HKT288), Anti-CDH6 / K-Cadherin Reference Antibody (HKT288), |
|||
| A998542 | Anti-Cdiff Toxin A Reference Antibody (actoxumab), Anti-Cdiff Toxin A Reference Antibody (actoxumab), |
|||
| A998543 | Anti-CEACAM1 / CD66a Reference Antibody (Chaim Sheba Med. Cntr. patent anti-CEACAM1), Anti-CEACAM1 / CD66a Reference Antibody (Chaim Sheba Med. Cntr. patent anti-CEACAM1), |
|||
| A998544 | Anti-CEACAM1 / CD66a Reference Antibody (CM-24), Anti-CEACAM1 / CD66a Reference Antibody (CM-24), |
|||
| A998545 | Anti-CEACAM5 / CEA / CD66e Reference Antibody (cergutuzumAb), Anti-CEACAM5 / CEA / CD66e Reference Antibody (cergutuzumAb), |
|||
| A998546 | Anti-CEACAM5 / CEA / CD66e Reference Antibody (Immunomedics patent anti-CEACAM5 (Class III)), Anti-CEACAM5 / CEA / CD66e Reference Antibody (Immunomedics patent anti-CEACAM5 (Class III)), |
|||
| A998547 | Anti-CEACAM5 / CEA / CD66e Reference Antibody (labetuzumab), Anti-CEACAM5 / CEA / CD66e Reference Antibody (labetuzumab), |
|||
| A998548 | Anti-CEACAM5 / CEA / CD66e Reference Antibody (tusamitamab), Anti-CEACAM5 / CEA / CD66e Reference Antibody (tusamitamab), |
|||
| A998549 | Anti-CEACAM6 / CD66c Reference Antibody (NEO-201), Anti-CEACAM6 / CD66c Reference Antibody (NEO-201), |
|||
| A998550 | Anti-CEACAM6 / CD66c Reference Antibody (tinurilimab), Anti-CEACAM6 / CD66c Reference Antibody (tinurilimab), |
|||
| A998551 | Anti-CHI3L1 Reference Antibody (Brown U. patent anti-CHI3L1), Anti-CHI3L1 Reference Antibody (Brown U. patent anti-CHI3L1), |
|||
| A998552 | Anti-Clathrin Heavy Chain / CHC Reference Antibody (Academia Sinica patent anti-Clathrin Heavy Chain), Anti-Clathrin Heavy Chain / CHC Reference Antibody (Academia Sinica patent anti-Clathrin Heavy Chain), |
|||
| A998553 | Anti-CLDN18.2 Reference Antibody (zolbetuximab), Anti-CLDN18.2 Reference Antibody (zolbetuximab), |
|||
| A998554 | Anti-CLEC12A / CD371 Reference Antibody (tepoditamab), Anti-CLEC12A / CD371 Reference Antibody (tepoditamab), |
|||
| A998555 | Anti-CLEC14A Reference Antibody (Scripps Korea patent anti-CLEC14A), Anti-CLEC14A Reference Antibody (Scripps Korea patent anti-CLEC14A), |
|||
| A998556 | Anti-CLEC4C Reference Antibody (BIIB059), Anti-CLEC4C Reference Antibody (BIIB059), |
|||
| A998557 | Anti-CLEC4C Reference Antibody (LFB patent anti-BDCA-2), Anti-CLEC4C Reference Antibody (LFB patent anti-BDCA-2), |
|||
| A998558 | Anti-CLEC7A Reference Antibody (Baylor patent anti-Dectin-1), Anti-CLEC7A Reference Antibody (Baylor patent anti-Dectin-1), |
|||
| A998559 | Anti-Clusterin Reference Antibody (AB-16B5), Anti-Clusterin Reference Antibody (AB-16B5), |
